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ABSTRACT
Background: Refugees and asylum seekers face various stressors due to displacement and are 
especially vulnerable to common mental disorders. To effectively manage psychological dis-
tress in this population, innovative interventions are required. The World Health Organization 
(WHO) Self-Help Plus (SH+) intervention has shown promising outcomes in reducing symptoms 
of common mental disorders among refugees and asylum seekers. However, individual parti-
cipant differences in response to SH+ remain largely unknown. The Individual Participant Data 
(IPD) meta-analysis synthesizes raw datasets of trials to provide cutting-edge evidence of 
outcomes that cannot be examined by conventional meta-analytic approaches.
Objectives: This protocol outlines the methods of a series of IPD meta-analyses aimed at 
examining the effects and potential moderators of SH+ in (a) reducing depressive symptoms at 
post-intervention and (b) preventing the six-month cumulative incidence of mental disorders 
in refugees and asylum seekers.
Method: RCTs on SH+ have been identified through WHO and all authors have agreed to share 
the datasets of the trials. The primary outcomes of the IPD meta-analyses are (a) reduction in 
depressive symptoms at post-intervention, and (b) prevention of six-month cumulative inci-
dence of mental disorders. Secondary outcomes include post-traumatic stress disorder symp-
toms, well-being, functioning, quality of life, and twelve-month cumulative incidence of mental 
disorders. One-stage IPD meta-analyses will be performed using mixed-effects linear/logistic 
regression. Missing data will be handled by multiple imputation.
Conclusions: These results will enrich current knowledge about the response to SH+ and will 
facilitate its targeted dissemination. The results of these IPD meta-analyses will be published in 
peer-reviewed journals.
Self-Help Plus para Refugiados y solicitantes de asilo; Protocolo de 
Estudio para una serie de Meta-análisis de datos de participantes 
individuales
Antecedentes: Los refugiados y solicitantes de asilo enfrentan numerosos estresores debido al 
desplazamiento y son especialmente vulnerables a trastornos de salud mental comunes. Para 
poder manejar efectivamente el malestar psicológico en esta población, se requieren inter-
venciones innovadoras. La intervención Self- Help Plus (SH+) de la Organización Mundial de la 
Salud (OMS) ha mostrado resultados prometedores en la reducción de síntomas de trastornos 
de salud mental comunes entre refugiados y solicitantes de asilo. Sin embargo, las diferencias 
individuales de los participantes en respuesta a SH+ permanecen mayormente desconocida. El 
meta-análisis de Datos de Participantes Individuales (IPD) sintetiza bases de datos puros para 
proveer evidencia de resultados de vanguardia que no puede ser examinada mediante 
enfoques meta-analíticos convencionales.
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HIGHLIGHTS
• Refugees and asylum  
seekers face enormous 
challenges and, thus, are at 
risk of mental disorders. 
• Low-intensity psychothera-
peutic interventions are 
needed to effectively 
address symptoms and 
prevent the full-blown 
onset of mental disorders 
in refugees and asylum 
seekers.  
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Objetivos: Este protocolo delinea los métodos de una serie de meta-análisis de IPD enfocados 
en examinar los efectos y potenciales moderadores de SH+ en (a) reducir síntomas depresivos 
en la post-intervención y (b) prevenir la incidencia acumulada de trastornos mentales en 
refugiados y solicitantes de asilo durante seis meses.
Método: Se identificaron RCT sobre SH+ a través de la OMS y todos los autores acordaron 
compartir la base de datos de sus ensayos. Los resultados primarios de los meta-análisis de IPD 
son (a) reducción en síntomas depresivos después de la intervención, y (b) prevención de la 
incidencia acumulada de trastornos mentales en refugiados y solicitantes de asilo durante 6 
meses. Entre los resultados secundarios de incluyó síntomas de trastorno de estrés 
postraumático, bienestar, funcionamiento, calidad de vida e incidencia acumulada de trastor-
nos de salud mental durante 12 meses. Se realizaran meta-análisis de IPD de una etapa usando 
regresión linear/logística de efectos mixtos. Los datos faltantes se manejaran mediante 
imputación múltiple.
Conclusiones: Estos resultados enriquecerán el conocimiento actual sobre la respuesta a SH+ 
y facilitarán su diseminación en su público objetivo. Los resultados de estos meta-análisis de 
IPD serán publicados en revistas revisadas por pares.
难民和寻求庇护者自助服务:一系列个人参与者数据元分析的研究方案
背景: 由于移居, 难民和寻求庇护者面临各种应激源, 尤其对常见精神障碍易感° 为了有效管 
理该人群的心理困扰, 需要采取创新的干预措施° 世界卫生组织 (WHO) 自助服务 (SH +) 干预 
在减轻难民和寻求庇护者的常见精神障碍症状方面表现出有前景的结果° 但是, 个体参与者 
对SH +的反应差异仍不清楚° 个人参与者数据 (IPD) 元分析综合了试验的原始数据集, 以提 
供常规元分析方法无法考查的结果的前沿证据° 目标: 本方案概述了一系列IPD元分析的方法, 旨在考查难民和寻求庇护者中SH +在 (a) 干预 
后减轻抑郁症状和 (b) 预防六个月的精神障碍累积发病率中的作用和潜在调节因素° 方法: 已通过WHO确定了关于SH +的RCT, 所有作者均同意共享试验数据集°  IPD元分析的主 
要结果是 (a) 干预后抑郁症状的减轻, 以及 (b) 预防六个月的精神障碍累积发病率° 次要结果 
包括创伤后应激障碍症状, 幸福感, 功能, 生活质量以及十二个月的精神疾病累积发病率° 一 
阶段IPD元分析将使用混合效应线性/逻辑回归° 缺失数据将通过多重插补处理° 结论: 这些结果将丰富关于SH +反应的现有知识, 并有助于其针对性传播° 这些IPD元分析的 
结果将发表在同行评审期刊上° 
1. Introduction
The past decade has seen a significant increase in the 
number of people who were forced to seek refugee 
status due to ongoing war, conflict or persecution in 
Syria, Iraq, Afghanistan, and South Soudan, among 
other countries (UNHCR, 2020, 2017a, 2017b). 
Destinations for the displaced individuals include 
Western European countries, such as Germany, 
Sweden, Finland and Austria (UNHCR, 2020), while 
Turkey is the country hosting most forcibly displaced 
individuals worldwide (roughly 3.6 million) (UNHCR, 
2020). This forceful displacement involves enormous 
mental and physical challenges to individuals and 
communities, including poverty, loss of livelihoods, 
violence, separation from family, discrimination, and 
resettlement issues (Fazel, Wheeler, & Danesh, 2005; 
Steel et al., 2009). Although many refugees and asylum 
seekers exhibit resilience and fortitude in the face of 
these difficulties, common mental disorders, like 
depression, are particularly prevalent in this popula-
tion as a result of stressful experiences before, during, 
and after displacement (Blackmore et al., 2020; 
Charlson et al., 2019; Fazel et al., 2005; Steel et al., 
2009). More specifically, according to a recent meta- 
analysis, depression is among the most common and 
persistent disorders in refugees and asylum seekers 
(31.5%) (Blackmore et al., 2020). Symptoms of depres-
sion may impair overall psychological functioning, 
wellbeing and overall quality of life, contribute to 
somatic health problems and somatization, and may 
lead to reduced possibilities to adjust to the new 
country (McGrath et al., 2020; Schick et al., 2016; 
Sijbrandij, 2018). Feasible and (cost-) effective inter-
ventions are warranted to manage symptoms of 
depression, reduce the probability of a full-blown 
onset of mental disorders, and improve quality of life 
in refugees and asylum-seekers Nevertheless, timely 
provision of psychological interventions is often ham-
pered by language barriers and limited access to the 
mental healthcare facilities in the host countries.
In this context, the World Health Organization 
(WHO) has developed a stress management pro-
gramme aimed at overcoming access-to-treatment 
barriers, reducing stress and improving overall func-
tioning, named Self-Help Plus (SH+). SH+ can be 
implemented in a group format, facilitated by a non- 
specialist peer-facilitator, using pre-recorded audios to 
deliver content. An illustrated stress management 
guide called ‘Doing What Matters in Times of Stress’ 
and accompanying audio exercises support practise 
outside of sessions. Such a task-sharing approach 
offers key-benefits by empowering community mem-
bers. This intervention is based on acceptance and 
commitment therapy (ACT), a form of cognitive beha-
vioural therapy that incorporates mindfulness and 
other acceptance-based practices to help people 
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adaptively cope with distress and commit to actions 
that are aligned with their values (Epping-Jordan et al., 
2016). Although ACT does not directly focus on 
symptom reduction, mounting research suggests that 
it is an effective treatment approach for common 
mental disorders like depression (Bai, Luo, Zhang, 
Wu, & Chi, 2020; French, Golijani-Moghaddam, & 
Schröder, 2017)
Thus far, SH+ has been shown to be feasible and 
acceptable when tested in pilot studies including refu-
gees and people affected by war (Purgato et al., 2019; 
Tol et al., 2018, 2018). Following these positive pre-
liminary findings, SH+ was tested with South 
Sudanese female refugees in Uganda in a cluster ran-
domized controlled trial (cRCT) (Tol et al., 2020). 
Results indicated strong improvements in psychologi-
cal distress in favour of SH+ compared to the control 
condition (i.e. enhanced treatment-as-usual) at post- 
intervention. Furthermore, SH+ resulted in improved 
personally identified problems, symptoms of depres-
sion, symptoms of post-traumatic stress disorder 
(PTSD), feelings of anger, overall functioning, social 
interactions, and well-being. Currently, the (cost-) 
effectiveness of SH+ in preventing mental disorders 
among forcibly displaced individuals in Western 
Europe and Turkey is being examined by two multi-
centre parallel-group RCTs. The first RCT is con-
ducted in Italy, Austria, Finland, Germany, and the 
UK and the second in Turkey (Purgato et al., 2019). 
Both RCTs aim to inform the wide implementation of 
SH+ in the given population (Purgato et al., 2019).
While the evidence-base around the effectiveness of 
SH+ is growing, it remains unclear how individuals 
may respond differently to this intervention. 
Individuals differ in various ways, including epide-
miological characteristics, background and living cir-
cumstances, life events they might have experienced, 
and type and severity of symptomatology. Such indi-
vidual differences may result in differential responses 
to the intervention. Some people may benefit more, 
whereas others may benefit less from the SH+ inter-
vention or even deteriorate. Understanding who is 
more likely to benefit from SH+ will substantially aid 
its targeted dissemination and implementation. 
Nevertheless, trials and conventional meta-analytic 
approaches are limited in their capacity to examine 
individual participant differences to intervention 
response. To achieve this goal, novel analytic strategies 
are required. The individual participant data (IPD) 
meta-analytic approach synthesizes raw datasets 
from clinical trials. In this way, sufficient statistical 
power is achieved to examine a range of moderators 
of intervention outcomes. Also IPD meta-analyses 
improve the precision of the overall estimates of the 
treatment effect (Bower et al., 2013).
In this study, we aim to conduct a series of IPD 
meta-analyses to synthesize available data from RCTs 
examining the effects of SH+ in refugees and asylum 
seekers. More specifically, we aim to examine:
(1) The effectiveness of SH+ compared to 
Enhanced Intervention-as-Usual (ETAU) in 
reducing depressive symptoms among refugees 
and asylum seekers. Secondary outcomes are 
reduction in post-traumatic stress and 
improvements in well-being, psychosocial 
functioning and quality of life.
(2) The effectiveness of SH+ compared to 
Enhanced Intervention-as-Usual (ETAU) to 
prevent the six-month cumulative incidence of 
any mental disorder among refugees and asy-
lum seekers. Secondary outcomes are preven-
tion of twelve-month cumulative incidence of 
any mental disorders.
(3) The moderating effects of participants’ socio- 
demographic, migratory, and clinical charac-
teristics to the differential effectiveness of SH+ 
relative to ETAU among refugees and asylum 
seekers.
2. Methods
The protocol registration is available in Open Science 
Framework (https://osf.io/jg4hs)
2.1. Identification of eligible studies
We will exclusively focus on examining the effective-
ness of the SH+ intervention. The complete SH+ 
package will be made publicly available by WHO in 
2021, and until that time all studies on SH+ need to be 
approved by the WHO. Thus, for the present study, 
a systematic literature search is not needed as WHO 
confirmed the existence of three RCTs on SH+ 
(Purgato et al., 2019; Tol et al., 2020), which are all 
on refugees and asylum seekers. The RCTs were con-
ducted in Uganda, Turkey, and one RCT was con-
ducted across five Western European countries (Italy, 
Germany, Finland, Austria, UK).
In this study, we will focus on examining modera-
tors of the effects of SH+ as compared to ETAU. Thus, 
uncontrolled pilot trials will be excluded from our IPD 
meta-analyses.
2.2. Participants and procedure
In the identified RCTs, participants were refugees and 
asylum-seekers (≥ 18 years of age) with elevated psy-
chological distress levels based on cut-off scores in 
self-report outcome measures [a score of ≥ 3 at the 12- 
item General Health Questionnaire – GHQ-12 for the 
RCTs in Turkey and Europe (Purgato et al., 2019) and 
a score of ≥ 5 on the Kessler-6 (K-6) in Uganda (Tol 
et al., 2020)]. ‘Refugees and asylum seekers’ were 
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individuals who (a) have been recognized as having 
a refugee status under the 1951 United Nations con-
vention (United Nations General Assembly resolution, 
1950), (b) sought international protection but whose 
application for refugee status had not yet been con-
cluded (United Nations General Assembly resolution, 
1950), or (c) were under temporary protection.
The RCTs in Turkey and Western Europe included 
both genders, whereas the RCT in Uganda included 
only females. The RCTs in Turkey and Western 
Europe excluded individuals meeting criteria for 
a DSM-5 diagnosis of mental disorder using the 
MINI Neuropsychiatric Interview and individuals suf-
fering from an acute medical condition (Sheehan et al., 
2010). Further, imminent risk of suicide was an exclu-
sion criterion in all three RCTs.
In terms of study procedures, the RCTs in Western 
Europe and Turkey used individual randomization, 
whereas the study in Uganda used cluster randomiza-
tion, in which 14 villages were randomized in either 
the intervention or the control groups to avoid con-
tamination of the intervention materials within vil-
lages (Tol et al., 2020).
2.3. Intervention
The SH+ intervention has been developed by WHO and 
is designed to help individuals cope with stress and 
manage adversity. SH+ comprises of five weekly ses-
sions, lasting approximately two hours. It is designed to 
be delivered in groups of up to 40 people and delivers 
content on: building awareness and grounding during 
stressful situations (session 1); noticing and naming 
difficult thoughts and feelings (session 2); identifying 
and acting on values (session 3), being kind (compas-
sion) towards self and others (session 4); accepting and 
living with difficult thoughts and feelings (session 5). 
Each session provides information and experiential 
practise on the core concept of that session, with addi-
tional time to review and practise previous content. 
Techniques throughout the course have a number of 
similar features so each concept builds on the last 
(Purgato et al., 2019; Tol et al., 2020).
The five sessions of SH+ are administered in 
a group setting by trained facilitators using a pre- 
recorded audio recording. This delivery mode poten-
tially reduces the time needed to train facilitators to 
deliver the content verbally. Instead, facilitators focus 
on managing the group and ensuring safety, as well as 
providing encouragement to practise the exercises 
contained in the audio recordings and answering addi-
tional questions that may arise. The audio provides 
psychoeducation about stress as well as instructions 
for experiential exercises. Moreover, SH+ is transdiag-
nostic (targets psychological distress broadly, includ-
ing symptoms of various psychological conditions like 
posttraumatic stress disorder, depression, anxiety in 
people with or without diagnosed mental disorders), 
easily adaptable to different cultures and languages (it 
has been used for research studies in English, Arabic, 
Dari, Urdu and Juba Arabic), and suitable for indivi-
duals with or without mental health problems. 
Depending on the cultural norms, SH+ can be deliv-
ered in groups with mixed or single-gender represen-
tation (Purgato et al., 2019; Tol et al., 2020).
SH+ is delivered by non-specialist facilitators 
trained in a task-sharing approach (Fulton et al., 
2011). In the studies, non-specialist facilitators had 
experience as volunteers, community workers or simi-
lar profiles and worked in healthcare or related set-
tings. It should be noted that many of the volunteers 
had a lived experience of being forcibly displaced and 
were drawn from the communities to which they 
delivered the intervention to. They received 4–5 days 
training and supervision on SH+ from local super-
visors who had received training in SH+ from WHO 
(Purgato et al., 2019; Tol et al., 2020).
2.4. Comparison
The identified studies compared SH+ to ETAU. In this 
control condition, participants received routine social 
support or healthcare support and treatment according 
to the local regulations and practices. Moreover, parti-
cipants in ETAU received information about all freely 
available social and mental healthcare services for refu-
gees and asylum-seekers individuals in the community.
2.5. Outcomes
In the planned IPD meta-analyses, we will have the 
following primary outcomes: (a) post-intervention 
depression symptom severity on PHQ-9 (Kroenke, 
Spitzer, & Williams, 2001) and (b) prevention of six- 
month cumulative incidence of any mental disorder 
based on a clinical interview. Secondary outcomes 
include reduction in post-traumatic stress symptoms 
on The Post-Traumatic Checklist-6 (Lang & Stein, 
2005; Weathers et al., 2013) and improvements in 
quality of life on WHODAS (Üstün, Kostanjsek, 
Chatterji, & Rehm, 2010) version 2, and functioning 
on PSYCHLOPS (Ashworth, Kordowicz, & Schofield, 
2012), and well-being on WHO-5 (Bech, 2004). 
Moreover, we will examine effects of SH+ on preven-
tion of the 12-month new incidence rates of any men-
tal disorder based on a clinical diagnostic interview.
2.6. Study-level variables
We will extract study-level data from the published 
reports of the trials including time of post-intervention 
assessment, country where the study was conducted, and 
type of randomization (cluster vs. individual randomiza 
tion), target group (e.g. South Sudanese female refugees), 
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and data related to the risk of bias assessment as described 
below (see section Risk of Bias assessment). One reviewer 
will extract the data from the published/under review 
reports and a second reviewer will check the extracted 
data for accuracy. In case, the reports of trials have not yet 
been published, the primary investigators will be asked to 
provide all the necessary information.
2.7. Individual-level variables
We will examine the role of a range of variables in 
moderating the effects of SH+ on the effects of the 
intervention. Moderator variables examine differential 
intervention effects on response (who benefits more or 
less from SH+ to ETAU). The variables will be chosen 
based on their availability in the included studies. We 
will gather and synthesize all socio-demographic (e.g. 
age, gender, educational and marital status, etc.), clin-
ical characteristics (e.g. levels of distress, previous 
psychological conditions, symptoms of depression, 
the exposure and type of traumatic events, the overall 
quality of life, functioning and wellbeing, etc.) and 
migration variables (time since resettlement, migra-
tion route, length of migration process, etc.) A full list 
of possible moderators is presented in Table 1.
2.8. IPD collection and aggregation
The research groups that have conducted the identified 
RCTs have agreed to contribute data to these IPD meta- 
analyses. The transfer of de-identified primary datasets 
will be done using secure password protected data links. 
Further, the data will be safely stored in a secure cloud 
service (Surfdrive) developed for the Dutch education 
and research community, which can only be accessed by 
the members of the IPD meta-analysis research team. 
Transferring, storing, and handling of data will follow 
the EU General Data Protection Regulations (GDPR).
After gathering all primary datasets of the eligible 
RCTs, the data will be checked against the published 
reports of the trials to ensure the accuracy of the 
dataset. More specifically, we will check the frequen-
cies of socio-demographic variables (e.g. age, gender, 
education, marital status, etc.) as well as the mean 
scores of continuous scales. In case inconsistencies 
are found (e.g. extreme values or discrepancies 
between the trial report and the data), these will be 
discussed and clarified with the authors of the primary 
studies. After checking each dataset, we will merge the 
data into the IPD meta-analytic dataset.
2.9. Risk of bias assessment
Two reviewers will examine independently the risk of 
bias for the primary outcomes in the three included 
studies using the criteria of the Cochrane 
Collaboration risk of bias assessment (RoB) tool 2.0 
(Sterne, Savović, & Page et al., 2019). This tool examines 
bias arising from randomization, deviations from 
intended interventions, missing outcome data, mea-
surement of the outcome, and selection of reported 
results. Given that the present study is an IPD meta- 
analysis, we will not evaluate bias related to missing 
outcome data and selection of reported results. We 
will exclude these domains of bias from the RoB assess-
ment because we will have access to the primary full 
datasets of the trials. The RoB will be evaluated based on 
the information provided in the published reports of the 
papers. However, if there are unclear items, the primary 
authors of the trials will be asked. We will evaluate each 
item of the RoB assessment tool 2.0 as at low or high 
risk of bias (Sterne et al., 2019).
2.10. The IPD meta-analysis
All analyses will be conducted in STATA (version 
16.0). The analysis will be conducted according to 
the intention-to-treat principle (all randomized parti-
cipants will be included in the analyses). We will use 
multiple imputation to handle incomplete outcome 
data at the post-intervention assessment. Missing 
values will be estimated under the missing-at- 
random assumption (20 imputations). To estimate 
the missing values, complete baseline variables will 
be used (e.g. distress levels at baseline, age, gender, 
etc.). We will also conduct a sensitivity analysis using 
complete cases only to test the difference between 
imputed and complete values.
To calculate the effectiveness of SH+ in reducing 
depressive symptoms, we will merge the IPD from all 
available studies using the ‘one-stage IPD meta- 
analytic’ approach, which combines all the IPD from 
all the studies to perform a single analysis. The ‘one- 
stage IPD meta-analysis’ will result in a ‘mega-trial 
analysis’ in which data will be analysed as if they 
belonged to a single trial with participants nested 
within studies. This approach allows for a more 
sophisticated modelling of the moderators and thus 
it is preferred over the two-stage IPD approach 
(Debray et al., 2018; Stewart et al., 2015).
To examine the effects of SH+ on reduction in 
depressive symptoms at post-intervention, we will 
perform a mixed effect linear regression with random 
intercept model with each trial having a random effect 
and a fixed effect for the intervention and the severity 
of depression symptoms. The severity of depressive 
symptoms at the post-intervention will be used as the 
dependent variable, while the condition will be the 
independent variable while adjusting for baseline 
depression symptom severity. The post-intervention 
depression scores on PHQ-9 will be used as the depen-
dent variable and trial arm condition (SH+ vs ETAU) 
as the independent variable, while controlling for 
baseline depressive symptom severity.
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To examine the effects of SH+ in preventing the six- 
month cumulative incidence of any mental disorder, 
we will focus only the trials including six-month 
clinical interviews and excluded individuals who met 
criteria for any mental disorder at the baseline 
(Purgato et al., 2019; Tol et al., 2020). We will perform 
a mixed effect logistic regression with random inter-
cept model with each trial having a random effect and 
a fixed effect for the intervention and the severity of 
depression symptoms. Six-month cumulative inci-
dence (yes/no) will be used as the dependent variable, 
while the condition will be the independent variable. 
In a similar manner, in secondary analyses, we will test 
the effects of SH+ in reducing the 12-month cumula-
tive incidence of any mental disorder.
We will calculate the standardized β coefficient for 
the examined comparisons. This estimate indicates 
how many SDs the dependent variable (depression, 
well-being, quality of life, and functioning) changes 
per SD increase in the predictor variable. Thus, the 
higher the β is the greater the effect of the predictor 
variable on the dependent variable, although there is 
no association among the variables if the β is 0.
To ensure robustness of our findings, the analysis of 
the main outcomes will be repeated using a ‘two-stage 
IPD meta-analytic approach’, in which we will analyse 
the IPD separately in each study and then combining 
the estimates to calculate the pooled effect sizes 
(Cohen’s d) (Cohen, 2013) for all outcomes using the 
random-effects model.
2.11. Participant- and study-level moderators
We will test whether socio-demographic, clinical vari-
ables and migration variables moderate the effects of SH 
+ at the post-intervention assessment. To examine the 
effects of potential moderators, we will add the interac-
tion between each moderator variable and SH+ effect 
on depressive symptoms into the mixed-effects linear/ 
logistic regression model. Each potential moderator 
variable will be added into separate bivariate models.
2.12. Heterogeneity
Statistical heterogeneity will be assessed with I2, with 
0% indicating no heterogeneity, 25% low heterogene-
ity, 50% moderate heterogeneity and 75% as being 
high heterogeneity (Higgins, Thompson, Deeks, & 
Altman, 2003). We will also calculate the 95% 
Confidence Intervals (CI) around I2 square to give 
the full magnitude of heterogeneity (Ioannidis & 
Trikalinos, 2007). The 95% CI will be calculated 
using the non-central chi-squared-based approach 
(Orsini, Bottai, Higgins, & Buchan, 2006).
2.13. Publication bias
The present IPD meta-analysis focuses on SH+ and 
intervention developed by WHO. Therefore, we have 
access to all datasets using this intervention up to date, 
Table 1. List of possible moderators.
Moderators Explanation & possible categories
Gender Male vs
Female
Age Continuous (in years)
Country e.g. Syria, Iraq, Nigeria
Relationship Status Not in a relationship vs
In a relationship
Educational Level Illiterate vs
Primary school/junior high school 
vs
High school vs
University degree and above
Years of education Continuous (in years)
Employment Employed vs
Other
Number of relatives 1–3 relatives
4–6 relatives
> 6 relatives





Family’s agreement for departure Yes/No
Route of migration Eastern Mediterranean route vs
African Mediterranean route vs
Other route




Travelled with company with friends/relatives vs
with other migrants vs
With others vs
Relatives in the country of origins Yes/No




Length of stay in host country Continuous (in months)
Living situation Living situation vs
Living with a partner/children vs
Living with parents vs
Living with others
Accommodation Refugee reception centre vs
Rented apartment
Distress levels at BL Continuous (standardized)
Length of stay Continuous (in months)
Post-traumatic symptoms at BL Continuous (PCL-C)
Depressive symptoms at BL Continuous (PHQ-9)
Traumatic experiences Either continuous (HTQ), or
● Lack of food or water Yes/No
● No Medical Access Yes/No
● Lack of Shelter Yes/No
● Imprisonment Yes/No
● Serious Injury Yes/No
● Combat Yes/No
● Rape or Sexual Abuse Yes/No






Quality of Life Continuous (WHODAS)
Abbreviations: HTQ: Harvard Trauma Questionnaire; PCL-C: Post- 
traumatic checklist; PHQ-9: Patient Health Questionnaire – 9 items; 
PSYCHLOPS: Psychological Outcomes Profiles; WHO-5: The World 
Health Organization – Five Well-Being Index; WHODAS: The World 
Health Organization Disability Assessment Schedule. 
These moderators have been chosen based on the availability across the 
eligible studies. Possible use of these moderators in the series of IPDMAs 
depends on whether the analyses will focus on the 3 or the 2 eligible 
studies.
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which means that publication bias is not applicable to 
the present work.
3. Discussion
SH+ has shown promise in the prevention and treat-
ment of common mental disorders among refugees 
and asylum seekers. In the present paper, we have 
described the procedures of a series of IPD meta- 
analyses aimed at examining the effects as well as 
individual participant differences in response to SH+ 
as compared to ETAU.
3.1. Strengths and limitations
RCTs and study-level meta-analyses often lack the 
power to identify statistically significant moderators 
of intervention response. The IPD meta-analytic 
approach offers key benefits to conventional methods 
as it allows us to examine outcomes that have not been 
reported by primary studies. Further, this methodol-
ogy maximizes the statistical power and precision in 
the estimates and enables testing of moderators at 
a meta-analytic level (Bower et al., 2013).
Nevertheless, we should anticipate several limita-
tions. First, there is a chance that clinically important 
moderator variables might not be available across all 
eligible studies, meaning that the number of observa-
tions might be small for specific variables. Thus, the 
overall statistical power of our analysis might be 
reduced. Also, clinical heterogeneity should be 
expected. For instance, we expect variability across 
participants due to factors such as legal status (e.g. 
refugees or asylum seekers), country of origin and 
living situation as they are not a homogenous target 
group. Moreover, SH+ was delivered in different set-
tings across countries, ranging from refugee camps to 
healthcare or community facilities, and this might 
impact the intervention’s effect. Finally, the identified 
studies differ in terms of depression severity. For 
instance, Tol et al. (2020) included a proportion of 
participants with likely mental disorders at entry into 
the trial, while this was an exclusion criterion in the 
other two eligible studies. To address this possible 
limitation, in our analyses, we will adjust for different 
levels of depression severity at baseline to improve the 
precision of our estimates and the interpretation of 
our findings.
Despite the potential limitations, synthesizing all avail-
able evidence of the WHO SH+ is needed for several 
reasons. First, to our knowledge, this would be the first 
IPD meta-analytic effort to examine moderators of 
a guided self-help intervention delivered by non- 
specialist facilitators. Given the novelty of the examined 
intervention in this context, pooling the data of all existing 
trials is needed to guide future studies in this field. It should 
be noted that although the number of eligible trials is small 
(n = 3), the number of total participants is large (n = 1795), 
thereby justifying the use of the IPD meta-analytic meth-
odology. Second, WHO intends to make the SH+ inter-
vention publicly available in 2021 for use. This low- 
intensity intervention delivered by non-specialists has the 
potential to bridge the gap between intervention supply 
and demand in the particularly vulnerable population of 
refugees and asylum seekers. Knowing who is more likely 
to respond to SH+ will ensure its most efficient dissemina-
tion and implementation providing timely access to effec-
tive care for psychological distress. Finally, the IPDMAs 
will importantly contribute to the knowledge base con-
cerning the effects of preventive interventions for adver-
sity-affected populations such as refugees and asylum 
seekers.”
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